Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

182 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
HER2 testing in gastric cancer: results of a German expert meeting.
Lordick F, Al-Batran SE, Dietel M, Gaiser T, Hofheinz RD, Kirchner T, Kreipe HH, Lorenzen S, Möhler M, Quaas A, Röcken C, Rüschoff J, Tannapfel A, Thuss-Patience P, Baretton G. Lordick F, et al. J Cancer Res Clin Oncol. 2017 May;143(5):835-841. doi: 10.1007/s00432-017-2374-x. Epub 2017 Mar 11. J Cancer Res Clin Oncol. 2017. PMID: 28285403 Free PMC article. Review.
[Treatment of gastric cancer].
Lordick F, Ridwelski K, Al-Batran SE, Trarbach T, Schlag PM, Piso P. Lordick F, et al. Onkologie. 2008;31 Suppl 5:32-9. doi: 10.1159/000163075. Epub 2008 Nov 14. Onkologie. 2008. PMID: 19033703 Review. German.
Cancer patients and the Internet: a survey of the 'Quality of Life' Working Groups of the Arbeitsgemeinschaft für Internistische Onkologie and the Nord-Ostdeutsche Gesellschaft für Gynäkologische Onkologie.
Gencer D, Tauchert F, Keilhauer N, Al-Batran SE, Stahl M, Oskay-Özcelik G, Hipp M, Leibbrand B, Prasnikar N, Trarbach T, Stoll C, van Kampen M, Hochhaus A, Lorenzen S, Hofheinz RD. Gencer D, et al. Onkologie. 2011;34(8-9):435-40. doi: 10.1159/000330940. Epub 2011 Aug 19. Onkologie. 2011. PMID: 21934343
Metastatic esophagogastric adenocarcinoma: trends in first-line treatment and predictive factors for the implementation of HER2 testing in clinical practice during the first year after trastuzumab market approval.
Gencer D, Al-Batran SE, Dada R, Hünerlitürkoglu AN, Gonnermann M, Kegel T, Scheiber H, Jordan WO, Burkholder I, Kellermann L, Hofheinz RD. Gencer D, et al. J Cancer Res Clin Oncol. 2013 Feb;139(2):337-45. doi: 10.1007/s00432-012-1335-7. Epub 2012 Oct 19. J Cancer Res Clin Oncol. 2013. PMID: 23080134
182 results